Psychiatry

General Internal Medicine

Questions discussed in this category

How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?

2 Answers available

What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?

Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.

1 Answer available

What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?

6 Answers available

How do you approach titration or transitioning to Cobenfy in patients currently on an antipsychotic?

1 Answer available

What approaches have you found most helpful for concurrent severe major depressive disorder and alcohol use disorder?

5 Answers available

How do you differentiate demoralization from depression during cancer treatment?

2 Answers available

When do you consider attributing isolated psychosis to an acute ischemic stroke?

1 Answer available

How do you transition patients between different long-acting injectable antipsychotics?

3 Answers available

When do you use seizure prophylaxis in patients on clozapine?

7 Answers available

How do you approach pharmacologic management of OCD in patients with comorbid bipolar disorder, particularly when considering SSRIs or clomipramine?

1 Answer available

Do you prescribe linezolid to patients who are concomitantly on an SSRI?

8 Answers available

How do you treat extrapyramidal symptoms secondary to anti-psychotic use in patients who have not benefited from cogentin or benadryl?

4 Answers available

Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (prn) if/when symptoms develop?

5 Answers available

When do you attribute tremors to lamotrigine?

1 Answer available

How do you differentiate between hyperactive delirium and excited catatonia?

1 Answer available

How do you engage and approach a patient presenting with psychotic symptoms who has demonstrated a pattern of malingering and also has polysubstance use disorder?

1 Answer available

What antidepressants are recommended for management of depression or anxiety in patients with spinal cord injuries?

Do you avoid certain antidepressants related to the risks on suppressing respiratory-drive which is potentially concerning in patients with high cord ...

1 Answer available

How do you manage tacrolimus-related psychosis?

2 Answers available

When do you consider the use of clonidine in gabaergic withdrawal and how do you approach the risk of masking the autonomic signs of withdrawal when it is used?

Would you consider the risk of masking autonomic signs of alcohol withdrawal with clonidine different from beta-blockers?

1 Answer available

What varying approaches do you take in suicide risk assessments?

Do you use different approaches in different settings (i.e., the ED vs. outpatient clinic)? Do you use different approaches for chronic vs acute suici...

3 Answers available

How do you approach managing perioperative anxiety in Mohs patients?

1 Answer available

How do you manage stroke-related abulia?

1 Answer available

Do you avoid SSRIs in patients with a history of RCVS?

2 Answers available

What work-up do you recommend in patients with early-onset dementia?

Which genetic/other testing should be considered in an early-onset dementia work-up?

1 Answer available

How do you evaluate patients with suspected pseudo-dementia?

1 Answer available

How do you approach the management of patients on lamotrigine who develop a minor rash?

Should one restart lamotrigine or look for an alternative? If no other alternative available, is slow titration vs regular titration preferred?

4 Answers available

How do you approach the workup and management of patients with suspected functional neurologic disorders?

What testing do you typically proceed with?

1 Answer available

Papers discussed in this category

JAMA network open, 2022 Dec 01

Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants.

International journal of antimicrobial agents, 2023 Jun 08

Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional study.

Pharmacy (Basel, Switzerland), 2023 Nov 20

The Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis.

International journal of antimicrobial agents, 2023 May 07

Real-world evaluation of linezolid-associated serotonin toxicity with and without concurrent serotonergic agents.

J Acad Consult Liaison Psychiatry, 2023 Nov-Dec

Delayed-Onset Psychosis Secondary to Tacrolimus Neurotoxicity After Lung Transplant: A Case Report and Systematic Review.

Case reports in nephrology and dialysis, 2021 Aug 04

When Paranoia Comes with the Treatment: Psychosis Associated with Tacrolimus Use.

The primary care companion for CNS disorders, 2022 Dec 08

Psychosis Associated With Tacrolimus at Therapeutic Serum Levels.

Transplantation direct, 2023 Jul 12

The Association of Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function.

Alcohol (Fayetteville, N.Y.), 2014-06

The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.

CNS drugs, 2024 Mar 19

An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders.

Neurology, 1991 Mar

Clozapine-related seizures.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2013 Aug 31

Use of anticonvulsants as prophylaxis for seizures in patients on clozapine.

Expert opinion on pharmacotherapy, 2023 Jun 27

Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches.

The American journal of psychiatry, 2010-06

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

Depression and anxiety, 2013-06

Prospective study of substance-induced and independent major depressive disorder among individuals with substance use disorders in a nationally representative sample.

Related Topics in Psychiatry